Roberta Giuffrida

Prof. Roberta Giuffrida

Department of Clinical and Experimental Medicine, Section of Dermatology, University of Messina, 98125 Messina, Italy
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2018 in Biomedicines
Verified
Journal Article
Open access
PDF file
Francesco BorgiaFrancesco Borgia
Francesco Borgia
Roberta GiuffridaRoberta Giuffrida
Roberta Giuffrida
ECEmanuela Caradonna
Emanuela Caradonna
Mario VaccaroMario Vaccaro
Mario Vaccaro
FGFabrizio Guarneri
Fabrizio Guarneri
SCSerafinella P. Cannavò
Serafinella P. Cannavò
Photodynamic Therapy (PDT) is a non-invasive treatment successfully used for neoplastic, inflammatory and infectious skin diseases. One of its strengths is represented by the high safety profile, even in elderly and/or immuno-depressed subjects. PDT, however, may induce early and late onset side effects. Erythema, pain, burns, edema, itching, desquamation, and pustular formation, often in association with each other, are frequently observed in course of exposure to the light source and in the hours/days immediately after the therapy. In particular, pain is a clinically relevant short-term complication that also reduces long-term patient satisfaction. Rare complications are urticaria, contact dermatitis at the site of application of the photosensitizer, and erosive pustular dermatosis. Debated is the relationship between PDT and carcinogenesis: the eruptive appearance of squamous cell carcinoma (SCC) in previously treated areas has been correlated to a condition of local and/or systemic immunosuppression or to the selection of PDT-resistant SCC. Here we review the literature, with particular emphasis to the pathogenic hypotheses underlying these observations.

2 August 2018 in Biomedicines
Verified
Journal Article
Open access
PDF file
Francesco BorgiaFrancesco Borgia
Francesco Borgia
Roberta GiuffridaRoberta Giuffrida
Roberta Giuffrida
FGFabrizio Guarneri
Fabrizio Guarneri
NINatasha Irrera
Natasha Irrera
Relapsing polychondritis is an immune-mediated systemic disease characterized by recurrent episodes of inflammation of cartilaginous and proteoglycan-rich tissues, resulting in progressive anatomical deformation and functional impairment of the involved structures. Auricular and nasal chondritis and/or polyarthritis represent the most common clinical features, but potentially all types of cartilage may be involved. Because of the pleomorphic nature of the disease, with non-specific symptoms at the onset, the diagnosis of relapsing polychondritis is often delayed. In this review article we provide a comprehensive look into clinical presentation, laboratory and instrumental investigations, diagnostic criteria, and therapeutic options.

3 February 2020 in International Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
CDCaterina Dianzani
Caterina Dianzani
CCClaudio Conforti
Claudio Conforti
Roberta GiuffridaRoberta Giuffrida
Roberta Giuffrida
PCPaola Corneli
Paola Corneli
NMNicola di Meo
Nicola di Meo
IZIris Zalaudek
Iris Zalaudek

11 March 2020 in Dermatologic Therapy
Verified
Journal Article
Closed access
PDF file
CCClaudio Conforti
Claudio Conforti
Roberta GiuffridaRoberta Giuffrida
Roberta Giuffrida
CDCaterina Dianzani
Caterina Dianzani
NMNicola Di Meo
Nicola Di Meo
IZIris Zalaudek
Iris Zalaudek
Click on the article title to read more.

20 October 2020 in Dermatologic Therapy
Verified
Journal Article
Closed access
PDF file
CCClaudio Conforti
Claudio Conforti
Roberta GiuffridaRoberta Giuffrida
Roberta Giuffrida
SFSara Fadda
Sara Fadda
AFAnnatonia Fai
Annatonia Fai
PRPaolo Romita
Paolo Romita
CDCaterina Dianzani
Caterina Dianzani

5 December 2020 in Biology
Verified
Journal Article
Open access
PDF file
CCClaudio Conforti
Claudio Conforti
CDCaterina Dianzani
Caterina Dianzani
MAMarina Agozzino
Marina Agozzino
Roberta GiuffridaRoberta Giuffrida
Roberta Giuffrida
GMGiovanni Francesco Marangi
Giovanni Francesco Marangi
NNNicoleta Neagu
Nicoleta Neagu
There have been increasing reports of skin manifestations in COVID-19 patients. We conducted a systematic review and included manuscripts describing patients with positive RT-PCR coronavirus testing from nasopharyngeal swabs who also developed cutaneous manifestations. A total of 655 patients were selected, with different types of skin rashes: Erythematous maculopapular (n = 250), vascular (n = 146), vesicular (n = 99), urticarial (n = 98), erythema multiforme/generalized pustular figurate erythema/Stevens-Johnson syndrome (n = 22), ocular/periocular (n = 14), polymorphic pattern (n = 9), generalized pruritus (n = 8), Kawasaki disease (n = 5), atypical erythema nodosum (n = 3), and atypical Sweet syndrome (n = 1). Chilblain-like lesions were more frequent in the younger population and were linked to a milder disease course, while fixed livedo racemosa and retiform purpura appeared in older patients and seemed to predict a more severe prognosis. For vesicular rashes, PCR determined the presence of herpesviruses in the vesicle fluid, which raised the possibility of herpesvirus co-infections. The erythema-multiforme-like pattern, generalized pustular figurate erythema and Stevens-Johnson syndrome were most frequently linked to hydroxychloroquine intake. A positive PCR determination of SARS-COV-2 from conjunctival swabs suggest that eye discharge can also be contagious. These cutaneous manifestations may aid in identifying otherwise asymptomatic COVID-19 carriers in some cases or predict a more severe evolution in others.